All terms in GO
| Label | Id | Description |
|---|---|---|
| obsolete negative regulation of S phase of mitotic cell cycle | GO_0045749 | [OBSOLETE. Any process that stops, prevents, or reduces the frequency, rate or extent of S phase of mitotic cell cycle activity.] |
| parahippocampal gyrus development | GO_0021770 | [The progression of the parahippocampal gyrus over time from its initial formation until its mature state. The parahippocampal gyrus is a ridge in the cerebral cortex.] |
| lateral geniculate nucleus development | GO_0021771 | [The progression of the lateral geniculate nucleus over time from its initial formation until its mature state. The lateral geniculate nucleus is the primary processor of visual information received from the retina.] |
| thalamus development | GO_0021794 | [The process in which the thalamus changes over time, from its initial formation to its mature state.] |
| retinoic acid receptor signaling pathway involved in ventral spinal cord interneuron specification | GO_0021774 | [The series of molecular signals initiated by binding of a ligand to a retinoic acid receptor in a precursor cell in the ventral spinal cord that contributes to the commitment of the precursor cell to an interneuron fate.] |
| retinoic acid receptor signaling pathway involved in spinal cord dorsal/ventral patterning | GO_0060895 | [The series of molecular signals generated as a consequence of a retinoic acid receptor binding to one of its physiological ligands that contributes to the dorsal ventral patterning of the spinal cord.] |
| positive regulation of epidermal growth factor-activated receptor activity | GO_0045741 | [Any process that activates or increases the frequency, rate or extent of EGF-activated receptor activity.] |
| regulation of epidermal growth factor-activated receptor activity | GO_0007176 | [Any process that modulates the frequency, rate or extent of EGF-activated receptor activity.] |
| smoothened signaling pathway involved in ventral spinal cord interneuron specification | GO_0021775 | [The series of molecular signals initiated by binding of a ligand to the transmembrane receptor smoothened in a precursor cell in the ventral spinal cord that contributes to the commitment of the precursor cell to an interneuron fate.] |
| regulation of epidermal growth factor receptor signaling pathway | GO_0042058 | [Any process that modulates the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity.] |
| striatal medium spiny neuron differentiation | GO_0021773 | [The process in which a relatively unspecialized cell acquires specialized features of a medium spiny neuron residing in the striatum.] |
| dendrite regeneration | GO_0031104 | [The regrowth of dendrites in response to their loss or damage.] |
| septin complex | GO_0031105 | [A protein complex containing septins. Typically, these complexes contain multiple septins and are oligomeric.] |
| septin cytoskeleton | GO_0032156 | [The part of the cytoskeleton (the internal framework of a cell) composed of septins and associated proteins. Includes septin cytoskeleton-associated complexes.] |
| septin cytoskeleton organization | GO_0032185 | [A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising septin complexes and their associated proteins.] |
| septin ring disassembly | GO_0031107 | [The controlled breakdown of a septin ring.] |
| organelle disassembly | GO_1903008 | [The disaggregation of an organelle into its constituent components.] |
| holo-[acyl-carrier-protein] biosynthetic process | GO_0031108 | [The chemical reactions and pathways resulting in the formation of holo-[acyl-carrier protein].] |
| microtubule polymerization or depolymerization | GO_0031109 | [Assembly or disassembly of microtubules by the addition or removal of tubulin heterodimers from a microtubule.] |
| hypoxanthine oxidation | GO_0006150 | [The chemical reactions and pathways resulting in the breakdown of hypoxanthine to xanthine and thence to uric acid.] |